Related Experiment Video
Updated: Dec 16, 2025

Preparing a Mice Model of Severe Acute Pancreatitis via a Combination of Caerulein and Lipopolysaccharide Intraperitoneal Injection
Published on: May 10, 2024
Aging and Comorbidities in Acute Pancreatitis I: A Meta-Analysis and Systematic Review Based on 194,702 Patients
Katalin Márta1,2, Alina-Marilena Lazarescu1,3, Nelli Farkas1,4
1Institute for Translational Medicine, University of Pécs Medical School, Pécs, Hungary.
Insights
Aging significantly increases the risk and mortality of acute pancreatitis (AP). Severe AP incidence and death rates rise linearly with age, with a sharp increase after 59, highlighting the impact of aging on AP outcomes.
Area of Science:
- Gastroenterology
- Geriatrics
- Epidemiology
Background:
- Acute pancreatitis (AP) is a leading cause of gastrointestinal hospitalization globally.
- While often mild, 10-20% of AP cases result in severe disease with increased mortality.
- Age is a recognized risk factor in established AP severity scoring systems.
Approach:
- A systematic literature search was performed across Embase, Cochrane, and PubMed.
- Meta-analysis included 33 publications with 194,702 AP patients, analyzed across seven age categories.
- Statistical methods included meta-regression and publication bias tests; quality was assessed using the modified Newcastle-Ottawa scale.
Key Points:
- Severe AP incidence increased linearly from 1.6% in those under 30 to 9.6% by age 70.
- Mortality rates showed a continuous rise until age 59, then increased ninefold by age 70.
- Patients over 70 had a 19-fold higher mortality risk compared to those under 20.
Conclusions:
- Advanced age is strongly associated with increased likelihood of severe acute pancreatitis and higher pancreatitis-related mortality.
- A critical inflection point for mortality elevation appears around age 59, suggesting the exacerbating role of comorbidities in older individuals.
Abstract:
Background: Acute pancreatitis (AP) is one of the most common cause of hospitalization among gastrointestinal diseases worldwide. Although most of the cases are mild, approximately 10-20% of patients develop a severe course of disease with higher mortality rate. Scoring systems consider age as a risk factor of mortality and severity (BISAP; >60 years, JPN>70 years, RANSON; >55 years, APACHE II >45 years). If there is a correlation between aging and the clinical features of AP, how does age influence mortality and severity? Aim: This study aimed to systematically review the effects of aging on AP. Methods: A comprehensive systematic literature search was conducted in the Embase, Cochrane, and Pubmed databases. A meta-analysis was performed using the preferred reporting items for systematic review and meta-analysis statement (PRISMA). A total of 1,100 articles were found. After removing duplicates and articles containing insufficient or irrelevant data, 33 publications involving 194,702 AP patients were analyzed. Seven age categories were determined and several mathematical models, including conventional mathematical methods (linear regression), meta-analyses (random effect model and heterogeneity tests), meta-regression, funnel plot and Egger's test for publication bias were performed. Quality assessment was conducted using the modified Newcastle-Ottawa scale. The meta-analysis was registered in the PROSPERO database (CRD42017079253). Results: Aging greatly influences the outcome of AP. There was a low severe AP incidence in patients under 30 (1.6%); however, the incidence of severe AP showed a continuous, linear increase between 20 and 70 (0.193%/year) of up to 9.6%. The mortality rate was 0.9% in patients under 20 and demonstrated a continuous linear elevation until 59, however from this age the mortality rate started elevating with 9 times higher rate until the age of 70. The mortality rate between 20 and 59 grew 0.086%/year and 0.765%/year between 59 and 70. Overall, patients above 70 had a 19 times higher mortality rate than patients under 20. The mortality rate rising with age was confirmed by meta-regression (coefficient: 0.037 CI: 0.006-0.068, p = 0.022; adjusted r2: 13.8%), and severity also (coefficient: 0.035 CI: 0.019-0.052, p < 0.001; adjusted r2: 31.6%). Conclusion: Our analysis shows a likelihood of severe pancreatitis, as well as, pancreatitis-associated mortality is more common with advanced age. Importantly, the rapid elevation of mortality above the age of 59 suggests the involvement of additional deteriorating factors such as co-morbidity in elderly.
Related Concept Videos
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Pharmacodynamics in Geriatric Patients: Effects of Age
Acute Pancreatitis II: Clinical Manifestations and Management
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Chronic Pancreatitis II: Collaborative Care
Assessment:
Acute Pancreatitis I: Introduction
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:

